Assessing readmission and mortality factors in COPD patients
A Prospective Study of Factors Related to Readmission and Mortality of COPD Patients in Hong Kong.
This study looks at what factors might lead to hospital readmissions and deaths in older patients with COPD to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT02815761 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the factors associated with readmission and mortality among patients with chronic obstructive pulmonary disease (COPD) in Hong Kong. Patients aged 40 and older who are admitted to the hospital with acute exacerbations of COPD will be recruited and assessed after their condition stabilizes. The study will collect demographic data and clinical information to identify trends and risk factors related to COPD outcomes. Written informed consent will be obtained from all participants.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 40 and older with a confirmed diagnosis of COPD experiencing acute exacerbations.
Not a fit: Patients with asthma, bronchiectasis, or other chronic lung diseases, as well as those unable to provide consent, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for COPD patients, potentially reducing readmission rates and mortality.
How similar studies have performed: Previous studies have provided insights into COPD morbidity and mortality, indicating that this approach is built on established research but focuses on specific local factors.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects with a diagnosis of COPD according to the Global Initiative for chronic Obstructive Lung Disease (GOLD) Guideline16 with previous spirometry showing FEV1/FVC ratio of \<0.70 with an AECOPD will be recruited for this study. 2. Age ≥40 years Exclusion Criteria: 1. Subjects who have been diagnosed with asthma, bronchiectasis or other chronic lung disease apart from COPD will be excluded 2. Patients with history of lung resection 4. Those who are unable to give consent
Where this trial is running
Hong Kong
- Prince of Wales Hospital — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Fanny Ko, MD — fannyko@cuhk.edu.hk
- Study coordinator: Fanny Ko, MD
- Email: fannyko@cuhk.edu.hk
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.